Literature DB >> 3279988

Malignant hyperthermia. Dantrolene--dynamics and kinetics.

G G Harrison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3279988     DOI： 10.1093/bja/60.3.279

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

1.  Early treatment of mild tetanus with dantrolene.

Authors:  J E Sternlo; L W Andersen
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.

Authors:  S S Palnitkar; J R Mickelson; C F Louis; J Parness
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

3.  Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia.

Authors:  R S Hotchkiss; I E Karl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

4.  Dantrolene inhibits halothane-induced membrane reorganization. A study using 31P-NMR and differential scanning calorimetry.

Authors:  S Gaillard; E J Dufourc; M Bonnet; J P Renou
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

Review 5.  Adverse effects of general anaesthetics.

Authors:  M C Berthoud; C S Reilly
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 6.  The cytoprotective effects of dantrolene: a ryanodine receptor antagonist.

Authors:  Saadet Inan; Huafeng Wei
Journal:  Anesth Analg       Date:  2010-09-22       Impact factor: 6.627

7.  Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series.

Authors:  Jacobo Lester; Gerardo Esteban Alvarez-Resendiz; Enrique Klériga; Fernando Videgaray; Gerardo Zambito
Journal:  Neurol Ther       Date:  2018-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.